OCS · NASDAQ

Oculis Holding AG

Q: How do I get OCS news from the API?

Call GET /v1/news?tickers=OCS. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.

$7.98 +0.08 (+0.96%)

Company overview

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for back-of-the-eye and front-of-the-eye conditions. The company's lead candidate is OCS-01, a topical dexamethasone formulation in Phase 3 clinical trials for diabetic macular edema; OCS-02, a topical biologic candidate in Phase 2b clinical trials for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.

Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
Market cap: $491M
Employees: 49
Headquarters: Zug
Website: oculis.com
CEO: Riad Sherif
Listed: May 18, 2021
P/E: -4.61
Dividend yield: 0.00%

Company financials

Revenue: $504,000
Gross profit: -$14.6M
Operating income: -$84.4M
EBITDA: -$84.7M
Net income: -$95.1M
EPS: -$1.73
Total assets: $243M
Total debt: $2.2M
Gross margin: -2,889.37%
Net margin: -18,861.29%
Earnings yield: -21.68%

Price chart

OCS 1D NASDAQ O7.80H7.98L7.72C7.90+0.07 (+0.95%)Vol66.93K

News

Ticker	Type	Headline	Source	Published
Loading headlines…

FAQ

Questions about Oculis Holding AG

What does Oculis Holding AG do?

What is OCS's market cap?

Oculis Holding AG (OCS) is a listed stock with a live quote. The latest market cap on this page is $491M.

Where is Oculis Holding AG headquartered?

Oculis Holding AG is headquartered in Zug.

How do I get OCS news from the API?

Call GET /v1/news?tickers=OCS. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.

How far back does OCS news go?

Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for OCS, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.

Is the OCS price on this page from the API?

The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Can I use the Pro plan commercially?

No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs